Decision Resources

Analyst Call: Psoriasis: The Uptake of Stelara in the United States: How are Physicians Integrating this IL-12/23 Inhibitor into a Market Dominated by TNF-alpha Inhibitors? - On Demand

June 15, 2010

Please enter the number of seats you would like to purchase for this event and click the add to cart button to continue to the checkout process.
Based on our Pharmacor advisory service entitled Psoriasis, Decision Resources is offering an exclusive analyst call entitled Psoriasis: The Uptake of Stelara in the United States: How are Physicians Integrating this IL-12/23 Inhibitor into a Market Dominated by TNF-alpha Inhibitors? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service. This analyst call was held on June 15, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.